Innate Pharma Income Statement (2017-2025) | IPHA

Income Statement Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.07B0.03B0.01B0.06B0.04B0.06B0.01B0.01B
Operating items
Research & Development (Quarter) -0.04B-0.09B-0.03B-0.06B0.00B-0.05B-0.03B-0.00B-0.03B-0.06B-0.03B-0.06B-0.02B-0.05B
Selling, General & Administrative (Quarter) -0.01B-0.03B-0.02B-0.02B0.01B-0.03B-0.01B-0.00B-0.01B-0.02B-0.01B-0.02B-0.01B-0.02B
Other Operating Expenses (Quarter) 0.000.00B0.000.00B
Operating Expenses (Quarter) -0.05B-0.12B-0.05B-0.08B0.01B-0.08B-0.04B-0.00B-0.04B-0.08B-0.04B-0.08B-0.03B-0.07B
Operating Income (Quarter) -0.01B0.01B-0.05B-0.00B-0.03B-0.03B
EBIT (Quarter) -0.03B-0.01B-0.01B0.01B-0.05B-0.00B-0.00B-0.01B-0.03B-0.06B-0.03B-0.06B
Non-operating items
Non Operating Income (Quarter) -0.00B-0.00B-0.00B-557.06
Net income details
EBT (Quarter) -0.02B-0.01B-0.00B0.01B-0.05B-0.00B0.00B-0.01B-0.03B-0.05B-0.02B-0.06B
Profit After Tax (Quarter) -0.02B-10.33B-0.08B-0.03B-0.06B-0.00B0.00B-0.01B-0.03B-0.05B-0.02B-0.06B
Net Income - Minority (Quarter) -0.19B-0.24B-0.19B-0.12B-0.06B-0.06B-0.01B0.03B
Income from Continuing Operations (Quarter) -0.02B-0.01B-0.00B0.01B-0.05B-0.00B0.00B-0.01B-0.03B-0.05B-0.02B-0.06B
Consolidated Net Income (Quarter) -0.02B-0.01B-0.08B0.01B-0.01B-0.00B-133.650.00B-0.01B-0.03B-0.05B-0.02B
Income towards Parent Company (Quarter) -0.19B-0.26B-0.01B-0.26B0.01B-0.13B-0.00B-0.06B0.00B-0.06B-0.03B-0.06B-0.02B0.03B
Net Income towards Common Stockholders (Quarter) -0.19B-0.26B-0.01B-0.26B0.01B-0.13B-0.00B-0.06B0.00B-0.06B-0.03B-0.06B-0.02B0.03B
Additional items
EPS (Basic) (Quarter) -2.62-3.020.00-0.00B0.00B-1.440.00-0.680.00B-14.71-0.00B-13.91-0.00B4.63
EPS (Weighted Average and Diluted) (Quarter) -0.00B-0.00B0.08-912.500.00B-0.00B-0.00B
Shares Outstanding (Weighted Average) (Quarter) 0.07B0.07B0.00B0.09B3.95B0.00B361.280.09B0.09B0.08B21.780.00B333.840.00B282.990.01B
Shares Outstanding (Diluted Average) (Quarter) 650.600.00B143.190.10B85.3621.78333.84282.99
EBITDA (Quarter) -0.03B-0.01B-0.01B0.01B-0.05B-0.00B-0.00B-0.01B-0.03B-0.06B-0.03B-0.06B
Interest Expenses (Quarter) -0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Shares Outstanding (Quarter) 0.09B0.09B0.09B0.08B0.09B0.09B0.11B